123 related articles for article (PubMed ID: 3970733)
1. Circulating natural killer cells in Sjögren's syndrome.
Ichikawa Y; Yoshida M; Takaya M; Uchiyama M; Shimizu H; Arimori S
Arthritis Rheum; 1985 Feb; 28(2):182-7. PubMed ID: 3970733
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P; Manthorpe R; Andersen V
Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
[TBL] [Abstract][Full Text] [Related]
4. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number.
Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K
J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772
[TBL] [Abstract][Full Text] [Related]
5. Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P; Manthorpe R; Andersen V
Scand J Rheumatol Suppl; 1986; 61():135-8. PubMed ID: 3473621
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens.
Fox RI; Hugli TE; Lanier LL; Morgan EL; Howell F
J Immunol; 1985 Jul; 135(1):207-14. PubMed ID: 3923102
[TBL] [Abstract][Full Text] [Related]
7. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P
Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
[TBL] [Abstract][Full Text] [Related]
8. [Cell-mediated immunity in patients with Sjogren's syndrome].
Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
[TBL] [Abstract][Full Text] [Related]
9. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.
Takeda A; Minato N; Kano S
Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073
[TBL] [Abstract][Full Text] [Related]
10. Natural killing activity in Sjögren's syndrome. An analysis of defective mechanisms.
Miyasaka N; Seaman W; Bakshi A; Sauvezie B; Strand V; Pope R; Talal N
Arthritis Rheum; 1983 Aug; 26(8):954-60. PubMed ID: 6882489
[TBL] [Abstract][Full Text] [Related]
11. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2.
Fox RI; Theofilopoulos AN; Altman A
J Immunol; 1985 Nov; 135(5):3109-15. PubMed ID: 3876375
[TBL] [Abstract][Full Text] [Related]
12. Studies of the function of natural killer-interferon system in patients with Sjögren syndrome.
Minato N; Takeda A; Kano S; Takaku F
J Clin Invest; 1982 Mar; 69(3):581-8. PubMed ID: 6174547
[TBL] [Abstract][Full Text] [Related]
13. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.
Adamson TC; Fox RI; Frisman DM; Howell FV
J Immunol; 1983 Jan; 130(1):203-8. PubMed ID: 6600176
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
Namkoong E; Lee SW; Kim N; Choi Y; Park K
Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subsets of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Takahashi K; Yoshida M; Moriuchi J; Takaya M; Arimori S
Clin Exp Rheumatol; 1989; 7(1):55-61. PubMed ID: 2785013
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
Bakhshi A; Miyasaka N; Kavathas P; Daniels TE; Strand CV; Herzenberg LA; Talal N
J Clin Lab Immunol; 1983 Feb; 10(2):63-9. PubMed ID: 6601716
[TBL] [Abstract][Full Text] [Related]
17. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome.
Fox RI; Adamson TC; Fong S; Young C; Howell FV
Diagn Immunol; 1983; 1(3):233-9. PubMed ID: 6238753
[TBL] [Abstract][Full Text] [Related]
19. Activation of T cell subsets in the peripheral blood of patients with Sjögren's syndrome. Multicolor flow cytometric analysis.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Arthritis Rheum; 1990 Nov; 33(11):1674-81. PubMed ID: 1700718
[TBL] [Abstract][Full Text] [Related]
20. Labial salivary gland immunopathology in Sjögren's syndrome.
Dalavanga YA; Drosos AA; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():67-70. PubMed ID: 3473652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
